Introduction {#s1}
============

The combinatorial binding of transcription factors to DNA define the gene regulatory regions that are essential for achieving spatial and temporal gene expression ([@bib86]; [@bib20]; [@bib27]). The rapid increase in empirically determined TF bound motifs ([@bib3]; [@bib33]; [@bib81]), sequenced genomes ([@bib24]; [@bib41]; [@bib2]), and genome-wide profiling of DNA--protein interactions has given us unprecedented insight into the location of gene regulatory regions in multiple tissue and cell types.

In particular, experimental results obtained by chromatin immunoprecipitation (ChIP), FAIRE, and DNase I footprinting assays in combination with high-throughput sequencing have unmasked what was previously a hidden landscape of active DNA regions ([@bib62]; [@bib19]; [@bib51]). The compendium of ChIP-seq determined DNA-binding for 119 different proteins in 72 cell experiments produced by the Encyclopedia of DNA Elements (ENCODE) consortium alone has revealed that the number of TF binding events greatly exceeds the number of genes in the genome and that over 8% of the genome can be bound by at least one TF ([@bib13]). The large number of TF bound genomic regions highlights the growing need for rational strategies for distilling these protein--DNA interactions into functional and non-functional categories. It has recently been shown that unlike TF binding events with high TF occupancy levels (measured by ChIP signal), genomic regions with low TF occupancy levels are not responsible for patterned reporter gene expression in *Drosophila* ([@bib16]). It remains to be seen how TF occupancy levels relate to functional gene expression in other species.

Comparing DNA between species has long been employed to identify transcription factor (TF) binding sites that comprise gene regulatory regions (e.g., [@bib75]; [@bib41]). Indeed, functional reporter gene expression assays have shown that many highly conserved mammalian non-coding regions serve as developmental limb and nervous system enhancers ([@bib55]). In contrast, other tissues including the heart ([@bib5]; [@bib47]), liver ([@bib34]), and adult brain ([@bib78]) possess many functional enhancers that do not show such deep phylogenetic preservation at the DNA level. An increasingly used way to identify tissue and species-specific gene regulatory regions is to compare experimentally determined TF--DNA interactions or histone modifications between species ([@bib35]; [@bib49]; [@bib69], [@bib67]; [@bib83]; [@bib10]; [@bib53]). For example, we previously established that the target genes of CEBPA and HNF4A, as identified from gene expression studies of conditional liver TF knockout mice, were enriched for TF binding shared in multiple species ([@bib69]). Similarly, functional *Drosophila* enhancers are more likely to be found in regions with conserved TF binding events detected by ChIP ([@bib53]).

Associating common genetic variation with complex traits is another powerful way to identify functional regulatory DNA in the human genome. Over 80% of the most significant single nucleotide polymorphisms (SNPs) associated with human phenotypes and disease occur within non-coding regions of the genome ([@bib30]). Recent integrative analyses have shown that open chromatin regions obtained for a specific cell type (e.g., DNase I hypersensitivity sites in T-cells) are enriched for reported GWAS SNPs. Importantly, this GWAS enrichment appeared most significant when the DNAse data was ascertained in a cell type relevant to the phenotype studied ([@bib46]; [@bib60]; [@bib66]). Examples of regulatory DNA mutations that explain differences in disease gene function are increasingly being discovered (e.g., [@bib50]) and there is tremendous interest in methods that can predict which non-coding variants are of functional consequence ([@bib66]; [@bib79], [@bib79a]).

To test whether evolutionary conservation of cis-regulatory modules (CRMs) gives insight into human gene regulatory function, we determined transcription factor (TF) binding locations of four liver-enriched TFs in liver tissue from: two primates (human and macaque) estimated to have diverged 29 million years ago; two rodents (mouse and rat) estimated to have diverged 25 million years ago; and dog which diverged during the mammalian radiation along with primate and rodent lineages ([@bib28]).

The liver is a suitable tissue for studying vertebrate gene regulation. It is a relatively homogenous tissue with approximately 75% of the nuclei in the liver coming from hepatocytes ([@bib43]). Both the relative homogeneity and the large cell numbers that can be isolated from diverse organisms under physiologically optimal conditions lend itself well to comparative studies. We focus on four TFs required for liver cell specification and gene function (HNF4A, CEBPA, ONECUT1, and FOXA1) ([@bib37]). Together, several studies have demonstrated that these four TFs work together directly and indirectly to drive liver-specific function ([@bib57]). Using liver as a model tissue, we demonstrate how a combinatorial analysis of TF occupancy across multiple species can highlight conserved and species-specific biological processes, as well as potential mechanistic actions of disease variants.

Results {#s2}
=======

Determining combinatorial binding in multiple mammalian species {#s2-1}
---------------------------------------------------------------

The genome-wide occupancy of four transcription factors (HNF4A, CEBPA, ONECUT1, and FOXA1) was determined in primary liver in five species (*Homo* *sapiens* \[Hsap\], *Macaca mulatta* \[Mmul\], *Canis familiaris* \[Cfam\], *Mus musculus* \[Mmus\], and *Rattus norvegicus* \[Rnor\]) using chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq) ([Figure 1](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}, [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}). The antibodies used for the four TFs have been raised against conserved epitopes and have previously been validated in ChIP experiments in mouse and human ChIP studies ([Figure 1---source data 1D](#SD1-data){ref-type="supplementary-material"}). As expected from previous multi-species ChIP study of CEBPA and HNF4A ([@bib69]), the known binding motifs for the four TFs was virtually identical between species and occurred close to the ChIP-seq binding summit ([Figure 1---figure supplement 1B,C](#fig1s1){ref-type="fig"}).10.7554/eLife.02626.003Figure 1.Overview of ChIP-seq, CRM construction, and multiple-species comparisons.ChIP-seq peaks were determined for four liver TFs in five mammals. (**A**) CRMs were constructed by merging ChIP-seq peaks whose summits occurred within 300 bp and consisted of at least two distinct TFs. Remaining peaks were designated as singletons. (**B**) Whole genome 9-way EPO multiple sequence alignments (MSA) were used to project CRMs/Singletons across the five species. A CRM was considered shared if its position in the EPO MSA overlapped a CRM in a second species by a minimum of 10 bp. Neither the content nor order of TFs within the CRM was required to be classified as a 'Shared' CRM. A singleton in one species was considered 'Shared' if it overlapped the same TF in a second species. (**C**) Relative to human, the average % of shared CRMs is shown. Human CRMs (comprised of any two TFs) that overlap a CRM from a second species are shown with empty circles. Human CRMs containing at least one of each TF (all 4 TFs) were compared to all identified CRMs in a second species (purple circles). (**D**) The percentage of human CRMs and singletons in different phylogenetic categories that can be found aligned within the EPO MSAs for each of the five species is shown.**DOI:** [http://dx.doi.org/10.7554/eLife.02626.003](10.7554/eLife.02626.003)10.7554/eLife.02626.004Figure 1---source data 1.Quality control for ChIP-seq, CRM construction, and multi-species comparisons.**DOI:** [http://dx.doi.org/10.7554/eLife.02626.004](10.7554/eLife.02626.004)10.7554/eLife.02626.005Figure 1---figure supplement 1.Summary of ChIP-seq peak number and TF motif enrichment.(**A**) Number of Peaks (**B**) Conservation of TF binding motifs. DNA binding specificities of CEBPA, HNF4A, FOXA1, and ONECUT1 are highly conserved. The known sequence motifs were identified de novo in each species interrogated. (**C**) Central position of motifs under TF binding summits were observed for each factor. Number of motifs identified using the PWM from B (y-axis) vs distance from TF binding summit obtained using the SWEMBL peak caller (x-axis).**DOI:** [http://dx.doi.org/10.7554/eLife.02626.005](10.7554/eLife.02626.005)10.7554/eLife.02626.006Figure 1---figure supplement 2.Pairwise analysis of individual TFs using EPO multiple sequence alignment.Shared binding events were initially identified in a pair-wise fashion using the 9-way EPO-MSA. Average % overlap was calculated and the total number of peaks that could be aligned to a second species is shown. The total peak number for each species shown in brackets. A region was identified as shared if its DNA sequence overlapped in a second species by 10 or more base pairs. (**A**) Average % overlap for the four individual TFs in this study. (**B**) For each pair of species the average % of CRMs (comprised of any two TFs) that overlap another CRM, regardless of its composition from a second species is shown. The number of CRMs present within the EPO-MSA is given on the right with the total number of CRMs shown in brackets. (**C**) For each species, CRMs containing at least one of each TF type (all 4 TFs) were compared to all identified CRMs in a second species ([Figure 1---source data 1F](#SD1-data){ref-type="supplementary-material"}).**DOI:** [http://dx.doi.org/10.7554/eLife.02626.006](10.7554/eLife.02626.006)10.7554/eLife.02626.007Figure 1---figure supplement 3.A majority of the four liver-enriched TFs cluster into CRMs.(**A**) The number of TF binding event clusters (y-axis) vs the distance between the summits of TF binding events used to generate the clusters (x-axis) is plotted. (**B**) Number of CRMs (y-axis) vs CRM width (x-axis) is shown for our chosen 300 bp distance-between-summit criteria we used to build CRMs. (**C**) Average width in base pairs for: all CRMS; CRMs containing all four TFs; and individual peaks are shown.**DOI:** [http://dx.doi.org/10.7554/eLife.02626.007](10.7554/eLife.02626.007)

Similar to what was observed for previous CEBPA and HNF4A ChIP-seq experiments, only a minority of ONECUT1 and FOXA1 bound regions overlapped orthologous, TF-bound regions in a second species, a relationship we refer to here as "shared" TF binding (see [Figure 1A,B](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}). The rapid evolution of TF binding is further supported by comparisons within primate and rodent orders that are separated by less than 25 million years ([@bib70]). For example, on average, between 21 and 37% of TF binding events in human are found in the orthologous location in macaque and 21--31% between mouse and rat for each of the TFs assayed ([Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}).

Tissue-specific TFs are known to bind in close proximity to form cis regulatory modules (CRMs). Similar to what has been done for multi-TF binding analyses in *Drosophila* ([@bib86]) and mouse ([@bib72]), we defined CRMs by clustering at least two proximal heterotypic TF binding events ([Figure 1A](#fig1){ref-type="fig"}). The number of liver TFs forming clusters falls off sharply when the distance between them is greater than 150 bp, which is less than the average width of the TF bound regions we detected by ChIP-seq ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). We built CRMs by merging TF binding events whose summits were within 300 bp of each other ([Figure 1](#fig1){ref-type="fig"}). Using this summit-based clustering, we found that approximately two thirds of the human liver TF binding events were incorporated into CRMs ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). We found that the shared CRM categories were robust to using a more permissive peak caller or calling peaks on individual biological replicates ([Figure 1---source data 1E](#SD1-data){ref-type="supplementary-material"}).

As we found for individual TFs, the location of CRMs appears to have evolved rapidly ([Figure 1C](#fig1){ref-type="fig"}). For example, we found that only ∼35% of human CRMs had a CRM in the orthologous macaque genomic region. Similarly, ∼32% of mouse CRMs were found as CRMs in the orthologous location in the rat genome ([Figure 1---figure supplement 2C](#fig1s2){ref-type="fig"}). This divergence of CRM occupancy was consistent between different lineages separated by the similar evolutionary distances ([Figure 1---source data 1F](#SD1-data){ref-type="supplementary-material"}), robust to the multiple sequence alignments (MSA) used to detect orthologous CRMs, and also robust to different overlap methods chosen to infer CRM conservation between species ([Figure 1---source data 1G](#SD1-data){ref-type="supplementary-material"}). [Figure 1D](#fig1){ref-type="fig"} shows that most (\>93%) of human CRMs and singletons we detect are found in the EPO MSA ([@bib54]) with macaque, which suggests that the rapid turnover observed between human and macaque CRMs is not due to characteristics of the multiple alignment.

CRMs containing all four TFs are on average more highly shared with a CRM from a second species (e.g., 53% of human CRMs with all four TFs are shared with a macaque CRM), indicating increased selection pressure on higher order combinatorial TF binding ([Figure 1C](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2C](#fig1s2){ref-type="fig"}). TF binding events shared in multiple species are more likely to be found within CRMs (72% of shared human TF binding events are in CRMs vs 27% that are classified as singletons; hypergeometric test, p = 8.48 × 10^−238^). For example, 32 of the 35 CEBPA binding events previously found to be bound in orthologous regions in five vertebrate species ([@bib69]) fell within CRMs identified in this study.

Comparative genomic analysis of combinatorial TF binding creates biologically meaningful categories from in vivo ChIP-seq data {#s2-2}
------------------------------------------------------------------------------------------------------------------------------

To test how combinatorial binding and TF binding conservation relate to liver gene function, we classified our set of human CRMs (n = 31,765) and singletons (n = 43,824) into phylogenetic categories ([Figure 2](#fig2){ref-type="fig"}, [Figure 2---source data 1](#SD2-data){ref-type="supplementary-material"}). CRMs were categorized as one of the following: shared only in human and macaque (Primates only, n = 4672); shared in human plus at least one non-primate (Beyond primates, n = 7631); and shared in at least three species (Deeply shared n = 5046) ([Figure 2](#fig2){ref-type="fig"}). The 43,824 singletons not residing in CRMs (44%) were categorized in the same manner ([Figure 2](#fig2){ref-type="fig"}).10.7554/eLife.02626.008Figure 2.Annotation of human regulatory regions using interspecies combinatorial transcription factor binding.(**A**) Human liver ChIP-seq data from ONECUT1, HNF4A, FOXA1, and CEBPA were assembled into CRMs consisting of at least 2 of the 4 TFs. The CRMs or single TFs were then broken down into categories based on their overlap with ChIP-seq data in macaque, dog, mouse, and rat. Singletons and CRMs were considered shared if they overlapped at least 10 bp with another TF bound region in the EPO multiple sequence alignment (MSA). (**B**) Experimentally determined combinatorial binding at the blood coagulation F7 locus. Raw sequencing reads from ChIP-seq experiments: CEBPA (red), HNF4a (green), ONECUT1 (yellow), and FOXA1 (green) are overlaid and called peaks are displayed for each species. ChIP-seq determined TF binding events were assembled into CRMs (black bars) underneath the enriched regions (peaks). Grey lines are drawn to illustrate shared CRMs using the EPO-MSA.**DOI:** [http://dx.doi.org/10.7554/eLife.02626.008](10.7554/eLife.02626.008)10.7554/eLife.02626.009Figure 2---source data 1.Table of CRMs and singletons along with the phylogenetic categories they were assigned.File coordinates are for the hg18 assembly.**DOI:** [http://dx.doi.org/10.7554/eLife.02626.009](10.7554/eLife.02626.009)

TF binding events contained in CRMs were enriched for their respective TF\'s DNA binding motif, in addition to other liver TF binding motifs, including those profiled in this study ([Supplementary file 1](#SD6-data){ref-type="supplementary-material"}). Supporting this observation, we find that both Deeply shared and human only CRMs overlap significantly with relevant ENCODE genome-wide experimental data sets, including ChIP peaks for HNF4A, FOXA1, and CEBPB in the liver cancer cell line HepG2 (e.g., p \< 10^−149^ and p \< 10^−212^ for HNF4 respectively; [Supplementary file 1](#SD6-data){ref-type="supplementary-material"}). The fold enrichment was higher for Deeply shared CRMs than for human only CRMs (e.g., 20.5 vs 11.8 for HNF4A). We also found significant overlap with TFs not tested in our study. For example, 51% of the Deeply shared CRMs and 20% of the human only CRMs overlap binding peaks for SP1 in HepG2 cells (p \< 10^−149^ and p \< 10^−212^ respectively; [Supplementary file 1](#SD6-data){ref-type="supplementary-material"}). Again the enrichment for these additional TFs was higher in the Deeply shared CRM category than the human only category (e.g., 17.6 vs 8.4-fold). SP1 and HNF4A have previously been shown to cooperatively regulate gene expression in HepG2 cells ([@bib74]). In this manner, Deeply shared CRMs can be used to enrich for additional TFs that might play global combinatorial roles in liver gene regulation when used in conjunction with other data sets from related cell types.

A comparison of shared CRMs to human-specific CRMs reveals an increase in the number of liver-related biological pathways, diseases, and known target genes of liver enriched TFs ([Figure 3](#fig3){ref-type="fig"}). We used the enrichment tool GREAT ([@bib48]) to perform functional enrichments. GREAT\'s default setting assigns TF binding events to a basal region around every gene (5 kb upstream, 1 kb downstream). ChIP-seq peaks that fall within the basal regulatory region of each gene, as well as the genomic sequence that spans between the basal region of that gene and the nearest gene\'s basal region (within a maximum of 1 Mb) are used to generate functional enrichments. The most significant enrichments that were unique to the shared liver CRMs include: liver disease (Binomial FDR q-value = 4.53 × 10^−130^) from the Disease Ontology database and metabolism of lipids and lipoproteins (q = 2.96 × 10^−73^) from MSigDB Pathway ([Figure 3A,B](#fig3){ref-type="fig"}, [Figure 3---source data 1A](#SD3-data){ref-type="supplementary-material"}).10.7554/eLife.02626.010Figure 3.Phylogenetic filtering of experimentally determined liver TF binding events yield distinct functional enrichments.Results were obtained using the programming interface for the online enrichment tool GREAT version 2.02 ([@bib48]) and plotted with custom R scripts. Up to five of the most significant enrichments obtained for each of the six analyses are listed on the left. The −log10 of binomial Q values for Disease ontology, HGNC gene family, and MSigDB are shown along the x-axis. Bars with a black asterisk indicate significant enrichments using GREAT default parameters (binomial and hypergeometric FDR Q-value significance at P ≤ 0.05 with at least twofold region enrichment). The size of the asterisk is proportional to the fold enrichment obtained for the given database. See [Figure 3---source data 1](#SD3-data){ref-type="supplementary-material"} for complete list of Q-values, fold enrichments, genes giving the enrichments along with results from additional databases. (**A**) Enrichment analysis of any CRM shared in human plus at least one additional species is shown on the left and human only CRMs are shown on the right ([Figure 3---source data 1A](#SD3-data){ref-type="supplementary-material"}). (**B**) Human CRMs (left panel) shared in human and at least one non-primate (Beyond Primates) is shown vs Human CRMs (right panel) shared in human and macaque but no other species (Primate only) ([Figure 3---source data 1B](#SD3-data){ref-type="supplementary-material"}). (**C**) Enrichment analysis of shared CEBPA CRMs and singletons ([Figure 3---source data 1C](#SD3-data){ref-type="supplementary-material"}). (**D**) Enrichment analysis of shared HNF4A CRMs and singletons ([Figure 3---source data 1D](#SD3-data){ref-type="supplementary-material"}). (**E**) Enrichment analysis of shared FOXA1 CRMs and singletons ([Figure 3---source data 1E](#SD3-data){ref-type="supplementary-material"}). (**F**). Enrichment analysis of shared ONECUT1 CRMs and singletons ([Figure 3---source data 1F](#SD3-data){ref-type="supplementary-material"}). (**G**) Human TFs in CRMs and Singletons were categorized by the number of species in which they are shared with. Profiles of constrained elements (sequence conservation) in a 1-kb window around CRMs or singletons were calculated using GERP scores from the 29-way multiple sequence alignments. (**H**) Genomic location of CRMs and Singletons. Proportion of single TFs located near transcription start sites (TSS) increases to \>50%, but remains stable for CRMs at ∼20%.**DOI:** [http://dx.doi.org/10.7554/eLife.02626.010](10.7554/eLife.02626.010)10.7554/eLife.02626.011Figure 3---source data 1.Functional enrichment results obtained for CRMs and singletons using GREAT.**DOI:** [http://dx.doi.org/10.7554/eLife.02626.011](10.7554/eLife.02626.011)

The most significant liver-related enrichments obtained using human only CRMs were for biological oxidations (q = 1.95 × 10^−39^; in MSigDB Pathway). These enrichments were driven by genes involved in the metabolism of xenobiotics by the cytochrome P450 gene family (q = 2.24 × 10^−19^; HGNC gene family database) ([Figure 3A](#fig3){ref-type="fig"}). Given the liver\'s major contribution to the detoxification of xenobiotics and the well established species-specificity of the proteins involved in the process ([@bib23]), these results suggest that evolutionary filtering of CRMs has the potential to enrich for both conserved and species-specific biological pathways.

Singleton TF binding events were predominantly enriched for their respective motif, but were not enriched for the motifs from the other three TFs profiled in this study ([Supplementary file 1](#SD6-data){ref-type="supplementary-material"}). Supporting this, comparisons against all ENCODE TF binding data show that for HNF4A, CEBPA, and FOXA1 singletons, the top ChIP-seq peak association in HepG2 cells corresponded to the TF assayed. HNF4A singletons were enriched for FOX family motifs, albeit not the same FOXA1 motif obtained from CRMs and singleton FOXA1 peaks. Comparing normalized sequence read counts in the HNF4A singletons, and HNF4A-containing CRMs lacking FOXA1 peaks, it is clear that pervasive weak FOXA1 ChIP-seq signal occur at HNF4A binding sites ([Figure 4A](#fig4){ref-type="fig"}). Further supporting this hypothesis is the similarity of FOXA1 to a portion of the HNF4A motif ([Figure 4B](#fig4){ref-type="fig"}), and a recent study that showed a close association of HNF4A with FOXA1 motifs ([@bib26]).10.7554/eLife.02626.012Figure 4.Comparison of TF occupied regions classified as CRMs and singletons.(**A**) Regions of ±5 kb are represented around the center of CRMs or singletons. Reads centered on the summit of each TF are counts subtracted by input reads in 100 bp bins plus and minus 5 kb from the summit. Colored boxes indicate CRMs or singletons where a peak was called for a given factor: CEBPA (red), HNF4A (blue), ONECUT1 (orange), and FOXA1 (green). Looking at read counts for all four factors reveal that many of the HNF4A singleton in fact have weak FOXA1 signal. (**B**) Alignment of FOXA1 de novo ChIP-seq motif to the HNF4A motif. Motif comparison (alignment) was performed using *compare-matrices* from RSAT. The program calculates the correlation between two matrices shifting positions; the correlation is normalized based on the width of the alignment to avoid high correlation based on few flanking positions.**DOI:** [http://dx.doi.org/10.7554/eLife.02626.012](10.7554/eLife.02626.012)10.7554/eLife.02626.013Figure 4---source data 1.Comparison of motif matches between CRMs and singletons. Chi-square test for differences between the number of peaks associated with CRMs and singletons, for each TF, that contained at least one predicted motif using three different p-value thresholds for motif scanning: stringent (10^−4^), moderate (10^−3^) and lenient (10^−2^). Blue shadows highlight siginficnat p-values.**DOI:** [http://dx.doi.org/10.7554/eLife.02626.013](10.7554/eLife.02626.013)10.7554/eLife.02626.014Figure 4---figure supplement 1.Comparison of stringent motif matches between CRMs and singletons.Each TF peak set was scanned using the RSAT tool matrix-scan with PWMs for the four TFs. A stringent motif cutoff (10^−4^) was applied. The figure shows the percentage of peaks with at least one detected site for each TF below the corresponding p-value threshold (y-axis) and the motif PWM scanned (x-axis). (**A**) Motif scanning in CEBPA peaks; (**B**) Motif scanning in FOXA1 peaks; (**C**) Motif scanning in ONECUT1 peaks; and (**D**) Motif scanning in HNF4A peaks. For the stringent thresholds, significant adjusted p-values comparing singletons and CRMs are given. See all *X*^2^ test p-values for lenient (10^−2^) and moderate cutoffs (10^−3^) in Figure 4---source data 1.**DOI:** [http://dx.doi.org/10.7554/eLife.02626.014](10.7554/eLife.02626.014)

We asked whether CRMs or singletons differ with regards to the quality of their TF binding motifs. Peaks for each TF were scanned using the RSAT tool matrix-scan with the best position weight matrices (PWM) for each TF. We set three p-value threshold cut offs (stringent:10^−4^, moderate:10^−3^ and lenient 10^−2^) based on the comparison between the theoretical and empirical PWM weight score distribution observed for each peak collection as previously described ([@bib48a]). As expected, motifs were identified in the vast majority of their corresponding peak set using the lenient motif threshold. Similarly, for both singletons and CRMs, the moderate and stringent motif searches returned the highest fraction motifs in their corresponding peak set. Interestingly, for both the moderate and stringent motif searches, the singleton TF binding sites had a significantly greater fraction of high quality motifs than they did for CRMs (e.g., 56% for singletons vs 33% for CRMs for the stringent cutoff). This trend was observed for all four TFs in this study ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}, [Figure 4---source data 1](#SD9-data){ref-type="supplementary-material"}). Our results in primary liver tissue are supported by an integrative analysis of ENCODE cell lines, which showed that active chromatin states are depleted of regulatory motif instances relative to all regions bound by a given TF ([@bib14]).

After collapsing the four TFs into CRMs, there were still over 40,000 singleton TF binding events. We asked if shared singletons show any distinct genomic properties. Shared singleton TF binding events show high DNA constraint ([Figure 3G](#fig3){ref-type="fig"}), and a larger fraction are found close to the transcription start site of annotated genes compared to the CRMs shared in the equivalent number of species ([Figure 3H](#fig3){ref-type="fig"}). Unlike the equivalently shared CRMs, shared singleton TF binding events gave fewer and less significant enrichments that than the equivalently shared CRMs ([Figure 3C--F](#fig3){ref-type="fig"}). Relative to CRMs, the enrichments unique to shared singletons, did not appear to be overtly liver specific. For example, no significant liver disease ontology enrichments were found for shared singleton CEBPA binding events; however, several cancer disease enrichments from various tissues, such as in situ carcinoma (q = 1.91 × 10^−5^), were obtained ([Figure 3C](#fig3){ref-type="fig"}).

One consideration about comparing singletons to CRMs is that singleton TF binding events are likely to become CRMs as more factors are tested and more peaks are called (see [Figure 1---source data 1E](#SD1-data){ref-type="supplementary-material"} for a comparison of the stability singleton and CRM categories). Nonetheless, by focusing on the singletons that remain singletons in orthologous regions in two or more species, we have been able to detect distinct genomic properties that warrant future study.

Shared combinatorial TF binding associates with highly expressed liver-specific genes {#s2-3}
-------------------------------------------------------------------------------------

To compare the functional properties of shared and species-specific CRMs/singletons, we then looked at how combinatorial binding and evolutionary constraint correlated with gene expression ([Figure 5](#fig5){ref-type="fig"}). Human TF binding events in CRMs and singletons were categorized by the number of species they were shared in and then associated with the nearest gene. Human liver mRNA expression level of the nearest gene was determined by RNA-seq ([@bib36]). Genes nearest to human-specific singletons and CRMs were not significantly different in their expression levels (p = 0.221). In contrast, gene expression levels near TFs in shared CRMs were significantly higher than those near shared singleton-associated genes (p = 2.4 × 10^−16^) ([Figure 5A](#fig5){ref-type="fig"}). This striking p-value is due to several CRMs being found close to highly expressed liver genes including albumin, fibrinogen (FGA, FGB, FGG), and several acute phase response genes (e.g., CRP, SAA1 etc). We therefore broke down each CRM and singleton by transcription factor, which still revealed a significant difference between genes close to Deeply shared CRMs relative to singletons (p \< 1 × 10^−3^; [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Using a reference transcription data set that comprises RNA-seq data for liver and 15 additional human tissue types (E-MTAB-513), we confirmed the above observation and found that the gene expression association with liver CRMs, and to a lesser extent singletons, was tissue-specific ([Figure 5B](#fig5){ref-type="fig"}). In sum, Deeply shared CRMs are associated with genes that are highly expressed in a distinctly liver-specific manner.10.7554/eLife.02626.015Figure 5.TFs in Deeply shared CRMs are near genes highly expressed in a tissue-specific manner.(**A**) Association of shared TFs in CRMs and Singletons with human gene expression obtained by RNA-seq in human liver ([@bib36]; E-MTAB-424). TFs in CRMs or Singletons were assigned to the nearest gene, and the FPKM (Fragments Per Kilobase of exon per Million reads) was recorded. In contrast to Singletons, TFs in Deeply CRMs are associated with highly expressed genes (adjusted p-values shown). The numbers of target gene associations for the singletons and CRMs in categories 1 to 5 are: 19354(S), 32706(CRM); 6325(S), 14669(CRM); 1935(S), 5755(CRM); 1005(S), 3292(CRM); and 459(S), 2530(CRM). (**B**) Comparison with CRMs and Singletons to a reference mRNA-seq data from 16 human tissues (E-MTAB-513) further shows that relative to singletons, liver-specific CRMs are highly expressed in liver, and that each TF contributes to this specificity. The number of gene associations for each category in the liver data is shown in white text within the heat map.**DOI:** [http://dx.doi.org/10.7554/eLife.02626.015](10.7554/eLife.02626.015)10.7554/eLife.02626.016Figure 5---figure supplement 1.Association of shared TFs in CRMs and Singletons with human gene expression obtained by RNA-seq in human liver ([@bib36]; E-MTAB-424) broken down by the transcription factor in the CRM: (**A**) HNFA; (**B**) CEBPA; (**C**) FOXA1 and (**D**) ONECUT1.TFs in CRMs or singletons were assigned to the nearest gene and the FPKM (Fragments Per Kilobase of exon per Million reads) was recorded for CRMs and TFs broken down by transcription factor. Adjusted p-values are shown and like [Figure 5](#fig5){ref-type="fig"}, the CRMs were associated with more highly expressed genes in the 5-way and 4-way--shared categories.**DOI:** [http://dx.doi.org/10.7554/eLife.02626.016](10.7554/eLife.02626.016)

Shared CRMs are enriched for tissue-specific biological function {#s2-4}
----------------------------------------------------------------

The number of reproducibly bound human regions obtained by ChIP-seq often exceeds the number of genes in the genome and so may require prioritization before experimental validation. Ranking ChIP-seq peak regions based on peak enrichment scores is one logical way to prioritize ChIP-seq peaks ([@bib16]). We compared the pathway enrichments for all shared CRMs containing a specific TF (e.g., the 6278 HNF4A-containing CRMs shared between human and at least one non-primate) vs the equivalent number of CRMs ranked by the best ChIP-seq peak enrichment score of that specific TF (e.g., the top 6278 HNF4A CRMs ranked by HNF4A peak score).

As expected, the HNF4A CRMs ranked by peak intensity showed higher read counts than the shared set of CRMs and both CRM sets showed strong, centralized motif enrichments ([Figure 6A](#fig6){ref-type="fig"}). However, by using overlap of CRMs in the EPO multiple sequence alignment as a filter, we found that shared CRMs give an increased number of significant enrichments using the ChIP-seq enrichment analysis tool, GREAT ([Figure 3---source data 1](#SD3-data){ref-type="supplementary-material"}). As observed for our collection of shared CRMs, the most significant enrichments for the shared CRMs are related to liver metabolic processes and disease ([Figure 6B](#fig6){ref-type="fig"}). Similar results were obtained by performing this comparison from the perspective of the other three TFs ([Figure 6B](#fig6){ref-type="fig"}).10.7554/eLife.02626.017Figure 6.Shared HNF4A CRMs unravel more liver related functional classes than do the equivalent number of CRMs with the best peak enrichment scores.CRMs containing each TF were analyzed separately. (**A**) Read count and motif binding weight scores were calculated for: (1) all CRMs (All); (2) CRMs shared in human and at least one additional non-primate (Beyond primates); (2) human CRMs shared in macaque only (Primates); and (3) the equivalent number of CRMs (equal to the number of Beyond primate CRMs) ranked by the SWEMBL peak intensity score for the TF in question (Top). (**B**) Functional enrichments were performed using GREAT comparing the Beyond primate category to the top ranked category. The top five enrichments for all comparisons performed were collected and the enrichments, if available are plotted. Databases used for GREAT enrichment analyses are indicated by color and are ranked according to the −log10 binomial FDR q-values plotted on the x-axis. Significant enrichments are labelled with an asterisk which is sized according to fold enrichment of the given database category.**DOI:** [http://dx.doi.org/10.7554/eLife.02626.017](10.7554/eLife.02626.017)

Lead SNPs from liver-related GWAS overlap Deeply shared CRMs {#s2-5}
------------------------------------------------------------

In order to determine whether shared CRMs associate with human diseases and phenotypes, we asked: (1) if the phenotype-associated single nucleotide polymorphisms (SNPs) in a curated collection of GWAS (described here as 'lead SNPs'; [@bib30]) overlap our CRMs/singletons in a liver-related manner; and (2) whether curated collections of these SNPs were enriched for shared CRMs ([Figure 7](#fig7){ref-type="fig"}, [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}).10.7554/eLife.02626.018Figure 7.Using a window of ±2.5 kb, lead SNPs obtained by GWAS were enriched for shared CRMs in a tissue/disease specific manner.Heatmap representation of the −log10 of Bonferroni corrected p-values from hypergeometric testing for enrichment of CRMs or single TFs (broken down into categories related to their degree of conservation) by lead GWAS SNPs obtained from the NHGRI catalog ([@bib30]). The NHGRI catalog disease traits were summarized into 25 categories prior to enrichment. Each GWAS lead SNP was given a ±2.5-kb window prior to identifying overlapping CRMs/singletons.**DOI:** [http://dx.doi.org/10.7554/eLife.02626.018](10.7554/eLife.02626.018)10.7554/eLife.02626.019Figure 7---source data 1.Full tables of 2.5 kb and LD GWAS enrichments performed in [Figure 7](#fig7){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}.The file also includes the categories used to annotate the NHGRI catalog.**DOI:** [http://dx.doi.org/10.7554/eLife.02626.019](10.7554/eLife.02626.019)10.7554/eLife.02626.020Figure 7---figure supplement 1.Using linkage disequilibrium (r^2^ ≥ 0.8), GWAS lead SNPs were enriched for shared CRMs in a tissue/disease specific manner.(**A**) Number of lead SNPs reported in the NHGRI catalog for each of the summarized GWAS categories. (**B**) CRM regions were classified depending on their conservation pattern. These categories were then intersected with summarized disease traits obtained from the NHGRI catalogue ([@bib30]). Linkage disequilibrium measures were calculated for lead SNPs from the NHGRI GWAS catalog up to a maximum of 100 kb flanking the lead SNP. Windows around each SNP were created based on the largest genomic interval between two SNPs in linkage disequilibrium (r^2^ ≥ 0.8). The heatmap shows the −log10 of Bonferroni corrected p-values for the enrichments of CRMs and singletons broken down into categories related to their degree of conservation determined by our multi-species ChIP-seq comparisons.**DOI:** [http://dx.doi.org/10.7554/eLife.02626.020](10.7554/eLife.02626.020)10.7554/eLife.02626.021Figure 7---figure supplement 2.Super-enhancer enrichments obtained by GWAS lead SNPs.'Super-enhancers' were directly obtained from [@bib31] and overlapped with lead GWAS SNPs annotated in the NHGRI catalogue ([@bib30]). Each lead GWAS SNP was given a 5-kb window prior to identify overlapping 'Super Enhancers'. The heatmap shows hierarchical clustering of the −log10 of corrected p-values for the enrichments of super-enhancers. A Hypergeometric test with Bonferroni correction was employed to assess the significance of enrichments in all categories. The heatmap shows significant enrichment of lead SNPs by immune cell super-enhancers. Super-enhancers from the liver cancer cell line HepG2 were not enriched for liver-related GWAS lead SNPs but were enriched for blood lipid related SNPs.**DOI:** [http://dx.doi.org/10.7554/eLife.02626.021](10.7554/eLife.02626.021)

Using hypergeometric testing, we found that liver-related GWAS lead SNPs were enriched for nearby (±2.5 kb from a SNP) Deeply shared CRMs. For example, we found lead GWAS SNPs related to liver (p = 8.38 × 10^−6^; 3.7-fold enriched), blood lipid (p = 9.68 × 10^−5^; 3.3-fold enriched), and drug response (p = 1.43 × 10^−4^; 5.1-fold enriched) categories were all enriched for shared CRMs ([Figure 7](#fig7){ref-type="fig"}, [Figure 7---source data 1A](#SD4-data){ref-type="supplementary-material"}). Repeating this analysis using linkage disequilibrium (LD) measures (r^2^ ≥ 0.8) to define the boundaries of each GWAS SNP gave similar results. For example, liver-related GWAS SNPs were enriched for Deeply shared CRMs when LD was taken into consideration (p = 3.20 × 10^−9^; 2.4-fold enriched; [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}, [Figure 7---source data 1B](#SD4-data){ref-type="supplementary-material"}). These enrichments were not found when using two distinct null models ([Figure 7---source data 1C,D](#SD4-data){ref-type="supplementary-material"}).

We then asked if any specific disease traits, as written in the NHGRI GWAS catalog, were enriched for shared CRMs. We found that for the 2.5 kb window analysis, only LDL cholesterol significantly enriched for Deeply shared CRMs (p = 0.037; 4.54-fold enriched; [Figure 7---source data 1E](#SD4-data){ref-type="supplementary-material"}), whereas the LD window analysis revealed 11 disease traits that were enriched for Deeply shared CRMs (see [Table 1](#tbl1){ref-type="table"}; [Figure 7---source data 1F](#SD4-data){ref-type="supplementary-material"}). For example, enrichments driven by lead SNPs for LDL cholesterol (blood lipid category, p = 4.84 × 10^−5^; 3.7-fold enriched) involved several loci including *TRIB1*, *ABCG8*, *APOB*, *SORT1*, *TOMM40*, *APOA5* and *HNF1A*. Lead SNPs for fibrinogen (liver category, p = 3.40 × 10^−3^; 3.4-fold enriched) occurred in LD with the fibrinogen locus. C-reactive protein (liver category, p = 1.17 × 10^−4^; 4.0-fold enriched) enriched for Deeply shared CRMs near CRP itself in addition to *RORA*, *MLXIPL*, *HNF1A*, *BAZ1B*, and *IRF1* loci ([Table 1](#tbl1){ref-type="table"}; [Figure 7---source data 1G](#SD4-data){ref-type="supplementary-material"}).10.7554/eLife.02626.022Table 1.Table of GWAS Disease Traits that significantly enriched for Deeply shared CRMs**DOI:** [http://dx.doi.org/10.7554/eLife.02626.022](10.7554/eLife.02626.022)Disease trait (NHGRI)Category (this study)Number of Deeply shared CRMsDeeply shared CRM enrichment (adjusted p-value)Fold enrichmentClosest genesOther metabolic traitsother measurement114.42E-056.42CRP, HNF1A, PANK1LDL cholesterolblood lipid204.84E-053.71TRIB1, ABCG8 PSRC1, DOCK7, APOB, HNF1A, LDLR, TOMM40, HNF1A, APOA5C-reactive proteinliver171.17E-043.97MLXIPL, RORA, CRP, HNF1A, TOMM40, BAZ1B, IRF1D-dimer levelsliver116.87E-044.99NME7, FGG, EDEM2, FGAFibrinogenliver153.40E-033.40FGB, FGA, FGGLung cancercancer144.39E-033.46C2, CRP, HSPA1A, TP63Mean corpuscular hemoglobinblood88.57E-035.02GCDH, USP49, RCL1, SLC17A1, TFRC, MPSTProtein quantitative trait lociother measurement142.49E-022.93CRP, IFT81, BCO2Serum markers of iron statusother measurement132.67E-023.03TCP1, MRPL18 , TF, SLC17A1, HIST1H4C, MPST, GHRTriglyceridesblood lipid122.84E-023.16TRIB1, MLXIPL, DOCK7, BAZ1B, GALNT2, TRIB1, APOA5Select biomarker traitsother measurement83.89E-024.08CRP, OR10J5[^5]

In order to explore the functional relevance of these findings, we looked for annotated regulatory SNPs in the RegulomeDB database ([@bib7]) within the 1020 CRM or single TF regions we found to be within 2.5 kb of a lead GWAS SNP. Of these 1020 regions, 753 contained at least one variant, 90% of which showed evidence of regulatory potential in RegulomeDB ([Supplementary file 2](#SD7-data){ref-type="supplementary-material"}). In particular, 317 of these 753 regions had TF binding in orthologous regions in additional species, making them rational candidates for future functional exploration.

We also asked whether the collection of recently identified 'super-enhancers' ([@bib31]), which were enriched for disease loci in a tissue-specific manner, would also enrich for liver-related lead GWAS SNPs. Our analysis supported the association between super-enhancers and immune system related GWAS SNPs reported by Hnisz et al. (with the highest enrichment for immune cell GWAS lead SNPs found in 'super-enhancers' in cell line CD20, p = 3.24 × 10^−6^). However, unlike what we found for shared CRMs in liver, super-enhancers obtained from the liver cancer cell line HepG2 were not enriched by the liver-related lead GWAS SNPs ([Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}). This observation may be related to biological differences between primary liver tissue and HepG2.

Shared CRMs are disrupted in known liver-related diseases affecting blood coagulation and lipid regulation {#s2-6}
----------------------------------------------------------------------------------------------------------

To further investigate the functional role of shared CRMs and to test the hypothesis that disruption of conserved combinatorial binding can lead to human disease, we overlapped our CRMs and singletons data with manually curated regulatory mutations directly linked to human disease (Human Genome Mutation Database Professional version; HGMD) ([@bib73]). This database contains the most comprehensive set of curated and functionally validated mutations that have occurred in human regulatory DNA regions and have led to a change in disease gene expression. A total of 157 genes associated with regulatory mutations overlapped our human ChIP-seq data, 106 of which were in our CRMs ([Table 2](#tbl2){ref-type="table"}; [Supplementary file 3](#SD8-data){ref-type="supplementary-material"}). The Deeply shared CRMs overlapped a set of 47 genes associated with regulatory mutations. These 47 genes were clearly enriched for two liver-related biological pathways: coagulation and complement factors (p = 9.34 × 10^−6^; 24-fold enrichment) and lipid homeostasis (p = 6.93 × 10^−5^, 36-fold enrichment) ([Figure 8---source data 1A,B](#SD5-data){ref-type="supplementary-material"}). We found multiple disease-causing regulatory mutations overlapping our CRMs at promoters of seven critical genes in the coagulation pathway (*FGA, FGB,* F7, F9, F10, F11, F12; [Figure 8](#fig8){ref-type="fig"}, [Figure 8---source data 1](#SD5-data){ref-type="supplementary-material"}). While many of these mutations have been individually known for decades, this is the first time they have been put in context of a regulatory network consisting of these liver-enriched TFs. Furthermore, repeated observation of rare mutations in the promoter regions of several of the blood coagulation proteins correspond to critical positions in predicted DNA binding motifs for the liver-enriched TFs. For example,Mutations leading to Factor VII deficiency and severe bleeding disorders occur in a promoter region harboring a CRM shared in all five species ([Figure 8---figure supplement 1A](#fig8s1){ref-type="fig"}). Several mutations (including SNP variant rs561241) within a conserved HNF4A motif have been shown to perturb F7 transcription leading to hemophilia ([@bib85]).A critical highly conserved CRM localizes to the F9 promoter ([Figure 8---figure supplement 1B](#fig8s1){ref-type="fig"}). Multiple mutations within this region are associated with defective expression of F9 and clinical hemophilia ([@bib21]). Several of these mutations have previously been shown to disrupt the binding of CEBPA and HNF4A ([@bib11]; [@bib12]; [@bib61]; [@bib21]). We recently demonstrated that ONECUT1 binds to the −6 site of F9 in human and mouse ([@bib18]). Inspection of the multiple species alignment suggests the same arrangement and spacing of CEBPA, HNF4A, and ONECUT1 motifs in the human and macaque CRMs, whereas the mouse and rat ONECUT1 motifs are predicted to begin three base pairs upstream.10.7554/eLife.02626.023Table 2.HGMD disease variants falling within motifs of shared CRMs and singletons**DOI:** [http://dx.doi.org/10.7554/eLife.02626.023](10.7554/eLife.02626.023)CoordinatesGene nameHGMD (regulatory, disease mutations)Disease mutations**Shared CRM**3:30622781-30623121TGFBR2Marfan syndrome II13:37009728-37010105MLH1Colorectal cancer, non-polyposis83:95175129-95175686PROS1Protein S deficiency23:172227012-172227583SLC2A2Diabetes14:187423808-187424193F11Factor XI deficiency15:176769019-176769427F12Factor XII deficiency27:75769704-75769860HSPB1Amyotrophic lateral sclerosis19:35647685-35648108RMRPCartilage-Hair hypoplasia[\*](#tblfn1){ref-type="table-fn"}609:103237817-103238177ALDOBFructose intolerance111:57121333-57121845SERPING1Angioneurotic oedema311:116213420-116213833APOA1Apolipoprotein A1 deficiency; Atherosclerosis with coronary artery disease212:119900361-119900931HNF1ADiabetes913:112807935-112808278F7Factor VII deficiency1517:39777939-39778164GRNAmyotrophic lateral sclerosis; Frontotemporal dementia219:11060834-11061300LDLRHypercholesterolaemia2319:40465042-40465277HAMPHaemochromatosis219:50140788-50141367APOC2Apolipoprotein C2 deficiency120:42417527-42417906HNF4ADiabetes13X:138440311-138440689F9Haemophilia B22**Shared singleton**1:55277551-55277787PCSK9Hypercholesterolaemia, autosomal dominant12:47483486-47483635MSH2Colorectal cancer, non-polyposis15:147191404-147191657SPINK1Pancreatitis511:107598900-107599060ATMAtaxia telangiectasia117:3486175-3486485CTNSCystinosis217:27840752-27841062CDK5R1Mental retardation119:54160105-54160315FTLCataract, bilateral1X:66680386-66680665ARProstate cancer1**Human only CRM**1:113300254-113300535SLC16A1Exercise-induced hyperinsulinism11:224075148-224075491EPHX1Hypercholanaemia13:170965492-170965762TERCAplastic anaemia; Dyskeratosis congenita; Myelodysplastic syndrome38:64161127-64161334TTPAAtaxia, isolated vitamin E deficiency110:27429312-27429620ANKRD26Thrombocytopaenia1213:59636050-59636246DIAPH3Auditory neuropathy1X:146800975-146801150FMR1Fragile X mental retardation syndrome3X:153643911-153644318DKC1Dyskeratosis congenita, X-linked1[^6][^7]10.7554/eLife.02626.024Figure 8.Shared CRMs link TF binding with disease-causing variants in coagulation and lipid regulation in the liver.Human CRMs that had TF binding in syntenic regions in at least two additional species (n = 5046) were intersected with the HGMD database. All protein coding genes associated with a regulatory mutation were analysed. Relationships among these genes were investigated and a representative analysis obtained using GeneMANIA ('Materials and methods'). Genes (large grey circles) are connected by pathways and protein--protein interactions are shown. The smaller white circles are genes predicted by GeneMANIA to be in the network. The 47 unique genes were associated into 35 clusters using DAVID ([@bib32]). Eight Gene Ontology terms from the 35 clusters had an adjusted p-value of less than 0.005 ([Figure 8---source data 1A](#SD5-data){ref-type="supplementary-material"}; [Supplementary file 3](#SD8-data){ref-type="supplementary-material"}). 4 of the 8 significant GO categories containing the most genes are illustrated: response to wounding (open red circle, p = 3.16 × 10^−9^; 9.9-fold enriched); blood coagulation (red dot, p = 9.34 × 10^−6^; 22.0-fold enriched); response to organic substance (open yellow circle, p = 1.05 × 10^−5^; 6.4-fold enriched); and lipid homeostasis (yellow dot, p = 6.93 × 10^−5^; 36.2-fold enriched).**DOI:** [http://dx.doi.org/10.7554/eLife.02626.024](10.7554/eLife.02626.024)10.7554/eLife.02626.025Figure 8---source data 1.Table of DAVID enrichments used to annotate [Figure 8](#fig8){ref-type="fig"} and the HGMD genes that overlapped our CRMs and singletons in the different phylogenetic categories.**DOI:** [http://dx.doi.org/10.7554/eLife.02626.025](10.7554/eLife.02626.025)10.7554/eLife.02626.026Figure 8---figure supplement 1.CRMs link TF binding with disease-causing variants in blood coagulation.Raw human ChIP-seq signals (bed graph format) are shown at the proximal promoters of three blood coagulation genes: (**A**) F7; and (**B**) F9. TF reads and significantly bound peak regions are shown as colored rectangles according to the TF (CEBPA = red; HNF4A = blue; FOXA1 = green; and ONECUT1 = yellow). All unique regulatory mutations in the HGMD overlapping human CRMs are shown with black arrows. Asterisks are shown above the position weight matrices for each TF at the position homologous to a unique human regulatory mutation (i.e., an A → T is only counted once). For each species, in silico predicted motif positions for each TF are shown above the multiple sequence alignment at each promoter when they overlap regions that have evidence of ChIP signal.**DOI:** [http://dx.doi.org/10.7554/eLife.02626.026](10.7554/eLife.02626.026)

In this analysis of known functional and disease causing regulatory mutations from the HGMD database, it is worth noting that most of the examples we found overlapping Deeply shared liver CRMs resided close to the TSS. As most TF binding of the factors we profiled occur outside of proximal promoters, it is likely that many more human mutations that regulate genes through long-range interactions remain to be found. Just as gene sequencing has uncovered a diverse array of mutations for most disease genes, we expect that disruption of conserved TF bound regions will be found to have pathological consequences.

Discussion {#s3}
==========

There is a great interest in identifying and mechanistically characterizing regulatory SNPs. Such approaches require limiting the genomic search space, finding the function of identified mutations, associating the mutation with target gene(s) and addressing the tissue-specificity inherent in transcriptional regulation. To limit the search space, the genome must be distilled to the active functional regions where mutations are likely to be pathological. To determine the function of mutations in gene control regions, the trans-acting molecules (e.g., transcription factors) whose regulation of a particular locus is disrupted need to be identified. Finally, because transcriptional regulatory networks are highly tissue-specific, regulatory regions can only be accurately done within the tissue concerned.

In this study, we demonstrated that genomic regions harboring shared combinatorial TF binding were enriched in a tissue-specific manner for essential biological pathways, common DNA variants associated with complex traits, and regulatory DNA mutations associated with rare diseases. In addition to the requisite measures of ChIP-seq data quality and reproducibility, it could be argued that combinatorial binding of transcription factors, relevant to the cell type of interest, increases the likelihood that the region identified is biologically important. However, more than half of the human liver TF binding sites detected in our study are in CRMs. In many cases, this makes CRM clustering on its own an insufficient filter for prioritizing TF binding sites for further study. Given the rapid turnover of TF binding within a mammalian lineage ([@bib72]), requiring combinatorial binding to be shared in multiple mammals is a strict filter that provides evidence that these biochemical interactions are under selection, even if the percent identity in the sequence alignments themselves is not exceptional. Supporting this idea, we found the percentage of CRMs shared between human and macaque (∼35%) and mouse and rat (∼34%) is considerably lower than the average human-rhesus sequence identity of ∼90% ([@bib63]) or the mouse-rat identity of ∼93% ([@bib22]).

Although insightful, the costs and challenges of performing comparative combinatorial TF binding in multiple species, tissues, developmental stages, and environmental conditions limits its widespread use as a method for finding enhancers. Computational strategies that forgo strict DNA constraint for more flexible criteria, such as shared clusters of motifs, show great promise ([@bib25]). For example, a recent computational strategy that relied upon conservation of clusters of motifs, rather than conserved DNA sequence, was able to fine map regulatory SNPs in select GWAS loci ([@bib8]). The results and the strong functional enrichments, we observe with shared combinatorial binding further support such approaches.

It is also becoming clear that integrative approaches to enhancer discovery can outperform predictions made using single criteria ([@bib15]). We compared our CRM and singleton data to enhancer predictions made by a recent integrative approach (EnhancerFinder; [@bib15]). EnhancerFinder is trained on experimentally verified human VISTA enhancers and utilizes evolutionary conservation, DNA motifs, and functional genomics data (such as p300 and histone modifications) as classifiers. We compared the 84,301 human developmental enhancers predicted by EnhancerFinder to our data. While all phylogenetic categories overlapped significantly ([@bib29]), the Deeply shared CRMs gave the highest overlap (∼30%) with the EnhancerFinder predictions. The evidence we present here for the functional relevance of Deeply shared combinatorial TF--DNA interactions in primary liver tissue suggests that results from such empirical studies in primary tissues will be another valuable source of information which can be utilized in integrative methods for enhancer prediction.

Just as using DNA constraint as a sole criteria for enhancer finding has its limitations, using filtering approaches that require conserved combinatorial binding will also miss important regulatory events near genes of interest. For example, the common SNP rs2279744 (also known as 'SNP 309') is found in the first intron of the *MDM2* and contributes to carcinogenesis in humans by increasing levels of MDM2, a negative regulator of TP53 ([@bib6]). This SNP has been shown to enhance the binding of the SP1 transcription factor at a site that does not have a clear orthologous mouse motif. For this reason, transgenic mice with human intron 1 alleles have been created and show a cancer phenotype ([@bib58]). This example illustrates where strictly using sequence conservation alone would fail to identify a functional regulatory variant. Interestingly, in our data we found a Deeply shared human HNF4A singleton TF binding event spanning rs2279744. Although the role of HNF4A at the MDM2 intron 1 has yet to be characterized, rs2279744 also serves as an example where excluding a presumptive singleton TF binding events from functional analyses would have missed an important regulatory variant.

Our results suggest that conserved liver regulatory regions reside near SNPs or rare mutations associated with liver related phenotypes. The most striking disease associations we observed involved the blood coagulation pathway. This pathway is perhaps one of the best-studied biological pathways and has long served as a model system for understanding human disease gene mutations. This rich history allowed us to observe, perhaps for the first time, how recurrent TF binding mutations found within conserved combinatorially occupied TF binding sites can be afflicted on several members of the same pathway. Conserved combinatorial control regions were also found near proteins that are part of the coagulation and complement system (e.g., C1R, C1S, C2, C4B, C4B, C4BPA, C4BPB, C5, C6, C7, C8A, C8B, C8G, C9, CFB, CFH, and CPB2). The interplay between the coagulation and complement system proteins has long been appreciated (reviewed by [@bib45]), and our results suggest that their gene expression in the liver is coordinated by conserved cis-regulatory modules.

Overall, the observation of recurrent phenotype-causing regulatory mutations in a single pathway is likely a phenomenon that occurs in other tissues and biological pathways. Our study suggests that identifying sites of shared combinatorial binding will be relevant criteria for assigning pathological significance to candidate disease variants uncovered in whole genome sequencing studies.

Materials and methods {#s4}
=====================

Molecular biology and genomics {#s4-1}
------------------------------

### Tissue preparation {#s4-1-1}

Tissues from all five species were treated post-mortem with 1% formaldehyde as previously described ([@bib68]). The dog liver material (Cfam; 2 adult males; 14 months of age) was obtained from commercial sources (Harlan). Human liver material (Hsap, 2 males, unknown age) was obtained from the Liver Tissue Distribution Program (NIDDK Contract \#N01-DK-9-2310) at the University of Pittsburgh and from Addenbrooke\'s Hospital, Cambridge under the human tissue license (08/H0308/117). Mmus (adult C57BL6/J males, 2.5 months of age) was obtained from the CRI under Home Office license PPL 80/2197. Macaque (Mmul) material was purchased from the CFM, UK.

### ChIP-Sequencing {#s4-1-2}

The CEBPA antibody sc-9314 (Santa Cruz Biotech, CA) and HNF4a antibody ARP31946 (Aviva Biosystems, CA) were used as previously described ([@bib69]). FOXA1 antibody ab5089 (Abcam, UK) has been previously used for FOXA1 ChIP--chip and ChIP-seq experiments in human and mouse ([@bib49a]; [@bib32a]). ONECUT1 (HNF6) anti-human polyclonal antibody sc-13050 (Santa Cruz Biotech) has previously been described for human and mouse ChIP--chip ([@bib52a]; [@bib81a]). Further details on the antigens used to raise the antibodies used for ChIP-seq are shown in [Figure 1---source data 1D](#SD1-data){ref-type="supplementary-material"}. Briefly, the immunoprecipitated material was end-repaired, A-tailed, ligated to single- or paired-end sequencing adapters, amplified by 18-cycles of PCR and size selected (200--300 bp) followed by single end sequencing on an Illumina Genome Analyzer II according to the manufacturer\'s instructions.

### Data {#s4-1-3}

ChIP-seq data generated for this study includes: CEBPA, FOXA1, ONECUT1, and HNF4A in rhesus macaque, FOXA1 in human, and FOXA1 and ONECUT1 in dog. Experiments used in this study that have been previously reported by our team include: ChIP-seq experiments for CEBPA and HNF4A for human and dog ([@bib69]; E-TABM-722); ChIP-seq for Hnf4a, Cebpa, and Foxa1 in C57BL6/J mice (E-MTAB-1414), as well as for Brown Norway rat (E-MTAB-1415) ([@bib72]); Human and mouse ONECUT1 ChIP-seq (E-MTAB-890) ([@bib18]); and RNAseq data for all five species ([@bib36]; E-MTAB-424). To facilitate analysis of this data set by others, all ChIP-seq files used here have been deposited in ArrayExpress under a single accession number (E-MTAB-1509). We filled genomic gaps in the coding regions for dog FOXA1 and macaque ONECUT1 and deposited them under NCBI accessions numbers JN601139 and JQ178331 respectively. Illumina BodyMap data were obtained from E-MTAB-513.

Computational biology and analysis {#s4-2}
----------------------------------

### Sequence alignment and peak calling {#s4-2-1}

ChIP-seq and input reads from each species were aligned with MAQ ([@bib40]) using default parameters to their respective genome assemblies (human \[NCBI 36\], macaque \[Mmul_1\], mouse NCBI m37; rat \[RGSC3.4\] and dog \[CanFam2.0\]). All sequence, genome annotations, and comparative genomics data were taken from Ensembl release 52.

For each TF, at least two biological replicates were performed and aligned to their respective genomes ([Figure 1---source data 1A--C](#SD1-data){ref-type="supplementary-material"}) ([@bib38]). Sequence reads from high quality replicates were pooled prior to calling peaks used for all comparative analyses and building CRMs. Peak calling was performed using SWEMBL with parameters '-R 0.005 -i --S' as described previously ([http//www.ebi.ac.uk/∼swilder/SWEMBL/](http://www.ebi.ac.uk/%7Eswilder/SWEMBL/); [@bib67]). The correlation of normalized read counts between biological replicates in the ChIP-seq data was further assessed using the DiffBind Bioconductor package ([@bib71]) ([Figure 1---source data 1C](#SD1-data){ref-type="supplementary-material"}). ChIP-seq data was also assessed using the quality control standards proposed by the ENCODE consortium and further described by [@bib44]. In the case where the second replicate could validate the first replicate, but gave substantially less peaks, we only used the one replicate that gave the most ChIP-seq binding events for our downstream comparative analyses. This occurred for: macaque CEBPA, macaque HNF4A, macaque FOXA1, and dog ONECUT1. Although the human female ONECUT1 was a good replicate, we only used peaks from the human male ONECUT1 experiment to confine our comparative analysis to one sex.

### Motif discovery {#s4-2-2}

Motif discovery was conducted with MEME ([@bib4]) using the default settings and the following parameters (-revcomp -maxw 20 -minw 6 -nmotifs 5). We selected the top 500 peaks ordered by input-corrected read depth and used the 25 bp centered on the identified summit of the peak as our input for the motif discovery analysis. As we previously reported for CEBPA and HNF4A, the position weight matrices (PWM) for FOXA1 and ONECUT1 were nearly identical between species ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}) ([@bib69]). For [Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}, we used the mouse PWMs for each TF to identify motif location within all of our CRMs using the programs PERL TFBS ([@bib39]) and CENTIPEDE ([@bib56]). This motif location information was used in conjunction with ChIP-seq signal to manually annotate promoters and regulatory variants ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}).

Search for secondary motifs was done using *peak-motifs* from RSAT ([@bib76]) with default parameters. *peak-motifs* uses a word count approach which enables users to input large sequence sets and recover motifs in a short time, in contrast with most alignment based approaches like MEME. CRMs and Singleton binding regions were classified in accordance to their conservation status, and these separated sets were used as input. Output motifs were compared with motifs discovered using MEME (see above) and external motifs coming from JASPAR (Vertebrate core 2009 version) ([@bib65]) and UniPROBE ([@bib52]) (2009 version) databases, in order to assign identity to the discovered motifs.

Motif comparison was performed using *compare-matrices* from RSAT. The program calculates the correlation between two matrices shifting positions; the correlation is normalized based on the width of the alignment to avoid high correlation based on few flanking positions ([Supplementary file 1](#SD6-data){ref-type="supplementary-material"}).

### Cis-regulatory module (CRM) construction {#s4-2-3}

We first computed the distances separating any two TF summits along the genome. ChIP-seq peaks were clustered into CRMs when the peak summits from at least two distinct TFs (e.g., CEBPA and HNF4A) fell within 300 bp (see [Figure 1](#fig1){ref-type="fig"} for graphical explanation). ([Figure 1A](#fig1){ref-type="fig"}, [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). All other TFs were treated as singletons.

### Interspecies overlap of transcription factor binding and CRMs {#s4-2-4}

Shared binding events and CRMs were identified using the 9-way Enredo-Pecan-Ortheus (EPO; [@bib54]) multiple sequence alignments from the Ensembl Compara database ([@bib17]). We performed these comparative analyses requiring different overlaps within the MSA criteria (1 bp, 10 bp, 25 bp, and 50 bp) ([Figure 1---source data 1G](#SD1-data){ref-type="supplementary-material"}). This range of parameters did not overtly affect the number of shared CRMs we retrieved. For the results presented, we define a CRM (or single TF) occupied region to be shared if it overlaps at least 10 bp of a CRM (or single TF) occupied region in a second species. See [Figure 2---source data 1](#SD2-data){ref-type="supplementary-material"} for all the CRMs and singletons along with their phylogenetic categories.

### Liver RNA-seq data analysis {#s4-2-5}

Liver RNA-seq data from the same species were used to analyze if CRM status and conservation were related to gene expression levels. Polyadenylated mRNA levels were assessed using previously described RNA-seq data (E-MTAB-424; [@bib36]). Briefly, trimmed 36 bp reads were aligned using TopHat and FPKM estimates were obtained using Cufflinks ([@bib77]) for all features annotated in Ensembl 52. Individual TF binding events and CRMs were associated to the nearest gene. The number of shared species for individual TF binding events and CRMs were recorded and associated with expression data.

### Illumina Body Map analysis {#s4-2-6}

We retrieved raw FASTQ files from ArrayExpress (accession E-MTAB-513). We first filtered these data with prinseq-lite (v0.15) and fastx (v0.0.13): we trimmed both read ends with a quality threshold of 20, and we then discarded those reads that were shorter than 35 nucleotides, had more than 5% of Ns, a dust score bigger than 10 (i.e., low complexity reads), and more than 5% of the bases with a quality inferior to 30. This subset of high quality reads was then mapped to the genome using BWA (v0.5.9, default options). We retrieved mapped reads and filtered them further by removing reads with a mapping quality below 20 (including multireads). In the case of paired-end data, we also removed all reads that were not properly paired. Finally, we calculated exon expression levels using htseq-count (HTSeq v0.5.3p3) and averaged those to produce gene expression estimates. TF binding sites not found in CRMs (Singletons) or within CRMs (Modules) were associated with the nearest gene. The FPKM (Fragments Per Kilobase of exon per Million reads) for each gene was recorded (obtained from the Human BodyMap 2.0 dataset from Illumina) and displayed as a heatmap ([Figure 5](#fig5){ref-type="fig"}).

### Comparison to ENCODE data {#s4-2-7}

We first compiled data relevant to transcriptional regulation from ENCODE, for all cell lines. For each ENCODE data set, we then calculated its observed overlap with each of our ChIP data sets (i.e., 'Deeply shared CRMs', and 'Shared Singletons') by counting the number of regions that overlap by at least 1 bp. We then built a distribution of expected overlap values from 1000 iterations of randomizing the input regions, by shuffling each one into a random genomic region chosen from among the DNaseI hypersensitive regions in any cell type (i.e., only shuffling them into possible regions of open chromatin, as a conservative estimate of possible regions where TFs might bind). The distribution of the overlap scores from the randomized data resembles a normal distribution, which we used to generate a Z-score and p-value for the observed number of peaks that overlap each real data set (see [Supplementary file 1](#SD6-data){ref-type="supplementary-material"}).

### Functional enrichment analyses using GREAT {#s4-2-8}

Functional enrichment of ChIP-seq data was performed using the online tool GREAT version 2.0.2 ([@bib48]). Importantly, GREAT is designed for ChIP-seq data analysis unlike hypergeometric enrichment analyses used for gene expression data. Hg18 assembly was used with the Association Rule: Basal+extension: 5 kb upstream, 1 kb downstream, 1000 kb max extension ([Figure 3](#fig3){ref-type="fig"}, [Figure 6](#fig6){ref-type="fig"}). GREAT figures were produced with an in-house R tool and are ranked according to the same default criteria used by the GREAT (binomial FDR q-value is ≤0.05 with a significant hypergeometric FDR q-value and a minimum region fold enrichment of 2). The −log10 binomial FDR q-values were plotted on the x-axis. Q-values for up to a maximum of five of the most significant enrichment categories obtained for each test data set are shown. Significant enrichments are labeled with an asterisk, which is drawn proportional to the fold enrichment value ([Figure 3---source data 1](#SD3-data){ref-type="supplementary-material"}).

### Overlap of shared CRMs with curated human regulatory mutations {#s4-2-9}

Human CRMs that had TF binding in syntenic regions in at least two additional species (n = 5046) were intersected with the Human Gene Mutation Database (HGMD; professional version). A representative network analysis of these genes was obtained using the GeneMANIA server using default parameters ([@bib80]). ([Figure 8](#fig8){ref-type="fig"}, [Figure 8---source data 1](#SD5-data){ref-type="supplementary-material"}). Using this data and the Default parameters for its Pathway analysis, GeneMania drew upon information from six sources (five of which are within Pathway Commons) and the sixth being [@bib82]. For its physical interaction analysis, it utilized 190 data sources supported by five data sets from iRefIndex ([@bib59]) and one study in BioGrid ([@bib84]). Functional annotation enrichment of these genes was performed using DAVID ([@bib32]).

### Location and GERP analysis of CRMs and singletons {#s4-2-10}

To define the locations of each regulatory region, we sliced the genome into categories: TSS ±3 kb, intronic, intergenic, and exonic. We obtained all transcripts (exons and introns) defined by the Ensembl genebuild, keeping the longest features. Any regions falling within ±3 kb of a TSS was characterized as the TSS ±3 kb category. In the event of complex gene arrangements or regions bridging two categories, we prioritized the locations as follows: TSS ± 3 kb \> intron \> intergenic \> exon. Conservation scores were obtained from the Ensembl Compara database ([@bib17]). Genomic Evolutionary Rate Profiling (GERP; [@bib9]) score was used to calculate the conservation of each nucleotide in multi-species alignment The multiple alignment used to derive GERP score is the 29-way EPO alignment. For CRMs and singletons, GERP scores were extracted for each base pair ±1 kb of the center of the CRMs or the peak summit for singletons.

### Intersecting GWAS with shared CRMs {#s4-2-11}

Linked SNPs and r^2^ values were obtained using the Ensembl Variation Perl API ([@bib64]) with the 1000 Genomes Project pilot 1 ([@bib1]) low coverage CEU panel genotypes. Linkage disequilibrium measures were calculated between target SNPs from the NHGRI GWAS catalog ([@bib30]) up to a maximum of 100 kb upstream and downstream of the lead SNP. Prior to overlapping with CRMs/singletons, windows around each SNP were calculated based on the largest genomic interval between two SNPs in linkage disequilibrium with the lead SNP (r^2^ ≥ 0.8). Alternatively, each GWAS lead SNP was given a window of ±2.5 kb. The GWAS catalog (25 August 2011) was manually summarized into 25 categories using the given Disease Trait, Experimental Factor Ontologies (EFO; [@bib42]), and the primary literature. The motivation for this classification was to group GWAS studies that had a clear tissue-specificity (e.g., liver, immune system) or disease type (e.g., diabetes, cancer) (see [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"} for overview of classification and [Figure 7---source data 1H](#SD4-data){ref-type="supplementary-material"} for the disease trait/summary key used). Lead SNPs whose window overlapped were collapsed into a single interval. Identical disease trait/summaries for lead SNPs within the same interval were counted only once.

We implemented two null models to further test the significance of the enrichments we found. First, we shuffled the GWAS SNP summary annotation 1000 times. Using each random set, we annotated CRMs and singletons with the summaries assigned to overlapping SNPs as described for [Figure 7](#fig7){ref-type="fig"}. We then calculated the enrichment for each summary term in the various phylogenetic categories. Second, we created a random set of SNPs from the full list of GWAS lead SNPs that matched the minor allele frequency and distance to transcription start site that we observed in our analyses in [Figure 7](#fig7){ref-type="fig"}. This was repeated 1000 times to create a null distribution of p-values. We considered an enrichment significant if less than 5% of the 1000 p-values obtained from either of the two null models had an enrichment p-value equal or lower to the one obtained using the original GWAS SNPs summary annotation sample before multiple testing correction.

Analyses were also performed by collapsing the NHGRI Disease Traits (see [Table 1](#tbl1){ref-type="table"}). All hypergeometric tests and heatmap plots were performed using R and were corrected for multiple testing.
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for sending your work entitled "Multi-species, multi-transcription factor binding highlights conserved control of tissue-specific biological pathways" for consideration at *eLife.* Your article has been favorably evaluated by Stylianos Antonarakis (Senior editor) and 2 reviewers (Drs Mike Beer and Ross Hardison).

The Senior editor and the reviewers discussed their comments before we reached this decision, and the Senior editor has assembled the following comments to help you prepare a revised submission.

There are several major points that need to be addressed in the revised document (please see below). In addition both reviewers have suggested a reorganization of the display items.

*Reviewer 1*:

1\) A main result is that most CRMs "are evolving rapidly", but to be precise, what "conserved" means here is that the sequences are not "alignable by EPO." This is naively in conflict with [Figure 1](#fig1){ref-type="fig"} showing that TFBS are conserved in all species. It seems that the authors have the ability to investigate what is evolving, either: 1) CRM TFBS composition (binding sites evolving in our out), 2) TFBS linear arrangement (binding sites reordered), or 3) CRM-gene association (entire CRMs relocating and losing synteny). Another possibility is that all 3 of these features are conserved, but what is called lack of conservation is simply a failure of EPO alignment to detect the conserved TFBS arrangement and composition. There are computational approaches specifically designed for this case (where PWMs and TFBS are known) which outperform EPO for this task (compared in Su Teichman Down 2010) and something along the lines of Kim, He, Sinha 2009; Sinha, He 2007; He, Ling, Sinha 2010; all in PLOS Comp Bio, should be utilized.

2\) Details of CRM construction are too sparse, and it is not very clear what CRM composition is until Supplemental [Table 2C](#tbl2){ref-type="table"}, which should be in [Figure 1](#fig1){ref-type="fig"}, and numbers of singletons should be added, not buried in the supplementary material. If a CRM changes its TFBS composition across species, but the sequence is alignable, is it still considered conserved?

3\) How sensitive are the results to the specific cutoffs used for ChIP-seq signal to quantify a binding event vs. non-event? The analysis should be performed on different replicates to test this. How many CRMs change their composition using only one repl to build them vs. the other? Also, it seems a bit inconsistent to say that the ENCODE quality control standards are used for the replicates if later only the replicate which gives the most peaks is used for downstream analysis. If both replicates don\'t give similar results, how robust are the conclusions?

4\) Motif detection is good, but enrichment should be quantified. The fraction of CRM sequences which have motifs present above some cutoff PWM score for each of the 4 PWMs should be reported for all CRMs and singletons. E.g., how many singleton HNF4A binding regions have a PWM instance above some cutoff, compared to how many singleton sites for the other 3 factors have a HNF4A PWM score above that same cutoff?

Reviewer 2:

The current manuscript is difficult to read and understand. I have several recommendations for revisions, starting with some major re-organization.

1\) The logical flow is fairly strong in the Results, but the data referred to are dispersed across many pages of Figures and Figure supplements. Also the order of the main figures does not fit with the presentation in the Results: it really is not used until the third section. I strongly recommend re-organizing the figures. Start with some of the current Figure 1 supplements, specifically [Figure 1--figure supplement 3](#fig1s3){ref-type="fig"}, 4, 5 to show the basic data, and how you constructed the CRMs, and the amount of conservation for TF bound sites and CRMs. Then go to the current [Figure 1](#fig1){ref-type="fig"}, which describes how the CRMs are categorized by extent of conservation.

2\) [Figure 2](#fig2){ref-type="fig"} and the many supplemental figures have multiple problems. The authors have developed an excellent way of displaying the GREAT results, but they flood the reader with too much information. A better-digested and focused set of key results needs to be featured. The text does have a good focus; however, the text and figures are not closely aligned. The specific examples of significant enrichments in the text are not listed in the main [Figure 2](#fig2){ref-type="fig"}, and the reader has to scan through four or five pages of figure supplements to find the data being discussed. One figure highlighting the key enrichments needs to be refined from all this material. Also, the method for assigning likely target genes is not stated in the main text. This is a very important point for interpreting the data, and it should be stated in the Results as well as in the Methods.

3\) The description and interpretation of the data in [Figure 4](#fig4){ref-type="fig"} need to be more accurate. The data in panel B are over-interpreted in the legend and in the Results. The expression of presumptive targets is not limited to liver ("uniquely expressed") but the expression levels are higher there. The text says "Unlike CRMs, conserved singletons do not show a strong increase in liver-specific gene expression." In fact, presumptive targets of singletons show a similar pattern to the presumptive targets of CRMs, but the levels of expression are lower. Is the decrease in signal for deeply shared singletons significant, or is this related to a small number of targets to examine? Also, the legend should specify the RNA-seq data used in panel A. The top comparison in [Figure 4A](#fig4){ref-type="fig"} seems to be between the expression levels of presumptive targets for deeply conserved CRMs and lineage-specific singletons, but it has a surprisingly high p-value; this should be clarified.

4\) [Figure 6](#fig6){ref-type="fig"} main and Figure 6--figure supplement 1: The authors are making a critical point but the connections between the text and the Figures are not stated clearly. In the Results, the authors give p-values for enrichment of about 0.005 to 0.008 and refer to [Figure 6](#fig6){ref-type="fig"}. However, those p-values are MUCH smaller, and correspond to the analysis in the next sentence, after separation by conservation categories. However, the reader is referred to Supplemental File 4, whereas they really need to look at [Figure 6](#fig6){ref-type="fig"}! The fact that the enrichments are robust to different ways of dealing with potentially functional SNPs in proximity or LD is a strong point and accurately stated in the Results. However, the titles to the figure legends ([Figure 6](#fig6){ref-type="fig"} vs. Figure 6--figure supplement 1) are the same, and it takes some careful reading to figure out what is different about the two figures.

5\) The Discussion should address what is missed by focusing on only combinatorial binding, only conserved binding, and both. Clearly, many fewer bound sites are examined by doing this filtering, but the enrichment for likely function is substantial. What are the potential costs of taking this approach?

6\) I would like to see a paragraph in the Discussion comparing the advantages of filtering vs integration. Are there integrative approaches that would emphasize the features shown to be useful here (combinatorial binding and conservation) while not completely excluding other binding sites?

7\) What is the null model for the tests of enrichment for GWAS SNPs in CRMs, singletons ([Figure 6](#fig6){ref-type="fig"})? In previous studies, the null model was restricted to SNPs on the genotyping array that were not associated with a trait but were matched to the trait-associated SNPs in several important ways, e.g. allele frequency, position relative to gene structure, and proximity to the transcription start site.
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Author response

Reviewer 1:

*1) A main result is that most CRMs "are evolving rapidly", but to be precise, what "conserved" means here is that the sequences are not "alignable by EPO." This is naively in conflict with* [*Figure 1*](#fig1){ref-type="fig"} *showing that TFBS are conserved in all species. It seems that the authors have the ability to investigate what is evolving, either: 1) CRM TFBS composition (binding sites evolving in our out), 2) TFBS linear arrangement (binding sites reordered), or 3) CRM-gene association (entire CRMs relocating and losing synteny). Another possibility is that all 3 of these features are conserved, but what is called lack of conservation is simply a failure of EPO alignment to detect the conserved TFBS arrangement and composition. There are computational approaches specifically designed for this case (where PWMs and TFBS are known) which outperform EPO for this task (compared in Su Teichman Down 2010) and something along the lines of Kim, He, Sinha 2009; Sinha, He 2007; He, Ling, Sinha 2010; all in PLOS Comp Bio, should be utilized*.

We thank the reviewer for pointing out the ambiguity on what we define as being conserved in this study. This is relevant to several other comments below. We have now replaced the term "conserved" with "shared" to make it clear that CRMs or Singletons that overlapped in the EPO multiple sequence alignment are what we are focusing on. This overlap in the EPO-MSA did not require more than 10 bp and was not based on CRM content or motif alignment. To better make this point, and to address reviewer 2's comment about organization of the manuscript, we created a new [Figure 1](#fig1){ref-type="fig"} to illustrate our method and terminology. We also indicate the fraction of human CRMs and Singletons of the different phylogenetic categories that fall within the EPO alignment of each of the other four species.

Using five mouse species/strains we recently described the evolution of CRM content and turnover (see [@bib72]). Based on the virtue of high quality multiple sequence alignments, and the controlled nature of tissue acquisition and biological variables that working with rodents affords, we believe that the results from [@bib72] provide a detailed answer to this important question. Here we did not attempt to track the gain and loss of individual TF binding within a CRM but rather we tried to use a "lenient" means of assembling CRMs (any two TFs) with the goal of capturing as many shared CRMs as possible for functional analysis.

Our new [Figure 1D](#fig1){ref-type="fig"} shows that most (\>93%) of human CRMs and singletons we detect are found in EPO with macaque, which suggests that the rapid turnover observed between human and macaque CRMs is not due to characteristics of the multiple alignment. Greater than 85% CRMs or singletons that are shared in at least one additional non-primate (Beyond primate category) are aligned within a non-primate species. This indicates that again the loss of a CRM in one or more species is unlikely due to the absence of the sequence in EPO.

While current methods which use only sequence properties will not necessarily be able to distinguish liver CRMs from all regulatory regions, these computational methods are highly relevant to compare to our dataset. We looked into the above papers and the methods reviewed in Su et al. 2010. From this paper the "Regulatory Potential Score" appeared to be the most promising and accessible regulatory prediction dataset we could compare to our data. Using the GAT tool [@bib29], we asked which of our phylogenetic categories were captured by the "ESPERR Regulatory Potential (7 species) described by Taylor et al. 2006 and Kolbe et al. 2004. As expected, of all of the phylogenetic categories significantly overlapped ESPERR regions, with the deeply shared CRMs having the highest overlap. ∼16% of the deeply shared CRMs within the deeply share CRMs overlapped ESPERR regions.

We also compared our data to a recent paper, which employed a novel method that successfully integrates a variety of functional data and sequence properties to predict developmental enhancers ([@bib15]). This method was trained on experimentally verified human VISTA enhancers and utilizes evolutionary conservation, DNA motifs and functional genomics data (such as p300 and histone modifications) as classifiers. EnhancerFinder clearly out performs individual classifiers for predicting enhancers. We compared the 84,301 predicted human developmental enhancers predicted by EnhancerFinder to our data. Again, as expected, all categories significantly overlapped the EnhancerFinder data, with the deeply shared CRMs giving the highest overlap. ∼30% of deeply shared CRMs overlap EnhancerFinder predictions. These results suggest that studies of combinatorial TF binding in primary tissues from multiple species will provide valuable datasets that are currently missed bin current integrative analyses. This result has been mentioned in the Discussion and incorporated into the response to Reviewer 2 comment 6.

*2) Details of CRM construction are too sparse, and it is not very clear what CRM composition is until Supplemental* [*Table 2C*](#tbl2){ref-type="table"}*, which should be in* [*Figure 1*](#fig1){ref-type="fig"}*, and numbers of singletons should be added, not buried in the supplementary material*. *If a CRM changes its TFBS composition across species, but the sequence is alignable, is it still considered conserved?*

This is a crucial comment raised also by reviewer 2. We have now provided a new Figure ([Figure 1](#fig1){ref-type="fig"}) illustrating the method for CRM construction. If a CRM changes TFBS composition and still remains a CRM, we consider it shared. We have also now consistently referred to the overlap of CRMs/singletons in our data as being "shared" rather than "conserved".

We also clarified the legends on the CRM building in what is now [Figure 1--figure supplement 3](#fig1s3){ref-type="fig"}. We moved the number of peaks and singletons out of the [supplemental File 1](#SD6-data){ref-type="supplementary-material"} and into called to the main [Figure 1--figure supplement 1A](#fig1s1){ref-type="fig"}. We also added a [Figure 2--data source file 1](#SD2-data){ref-type="supplementary-material"} which has all the CRMs and singletons along with their phylogenetic categories listed.

*3) How sensitive are the results to the specific cutoffs used for ChIP-seq signal to quantify a binding event vs. non-event? The analysis should be performed on different replicates to test this*. *How many CRMs change their composition using only one repl to build them vs. the other? Also, it seems a bit inconsistent to say that the ENCODE quality control standards are used for the replicates if later only the replicate which gives the most peaks is used for downstream analysis. If both replicates don\'t give similar results, how robust are the conclusions?*

We asked how building human CRMs with: 1) individual ChIP-seq biological replicates or 2) using a different peak caller (MACS), affected the phylogenetic classification of CRM/Singletons. We built human CRMs with the replicate that gave the most peaks "Hi rep" and with the replicate that gave the fewest peaks "Lo rep". We also used the MACs peak caller at an FDR of 0.05, which is more permissive at calling peaks than SWEMBL. The results for this comparison is tabulated and plotted in [Supplemental File 1F](#SD6-data){ref-type="supplementary-material"}. This comparison shows: overall the shared CRMs were robust to replicate and peak caller differences; few CRMs classified in this study became singletons using different replicates or peak caller; the majority of new peaks called fell into human only singletons; when a newly called CRM was classified as a singleton TF binding event in our study, the majority of these new CRMs were shared only in human. Finally when more peaks were called (e.g., using MACs or our "Hi rep" replicate ChIP-seq data), approximately 40% of the shared human singletons identified in our study became classified as CRMs. Although it is not unexpected that the singleton TF binding category is more unstable than the CRM category, our comparative analysis of shared singleton TF binding category has yielded novel genomic features (e.g. proximity to the TSS, high DNA constraint, and a relative reduction in liver-specific enrichments) which warrant future exploration. We have now raised this point in our Results and included this analysis in [Figure 1--source data 1](#SD1-data){ref-type="supplementary-material"}.

[@bib44] recently performed the ENCODE QC of [@bib38] on all the public ChIP-seq data in the NCBI GEO database. As our previously published (and of course unpublished) primary data is in ArrayExpress, our multi-species ChIP-seq data had not been subject to this QC. We felt that having this QC performed on our data would allow others who wish to use our data to quickly get a sense of its quality. In Landt et al, they do suggest cases where one replicate is used for a study and suggest that such cases, if they occur, should be explained. We now cite [@bib44] in this manuscript to justify our use of ENCODE quality control measures. We hope that addressing the reviewers comments regarding the CRM quality have made it clear that we have done our best to assemble and compare CRMs. We have raised this issue in the discussion as part of the answer to Reviewer 2 comment 5 and in the singleton versus CRM results section.

*4) Motif detection is good, but enrichment should be quantified. The fraction of CRM sequences which have motifs present above some cutoff PWM score for each of the 4 PWMs should be reported for all CRMs and singletons*. *E.g., how many singleton HNF4A binding regions have a PWM instance above some cutoff, compared to how many singleton sites for the other 3 factors have a HNF4A PWM score above that same cutoff?*

We thank the reviewer for this suggestion. We performed this analysis and have incorporated the results into the paper (text starting "We asked whether CRMs or singletons differ with regards to the quality of their TF binding motifs. Peaks for each TF were scanned using the RSAT tool matrix-scan with the best position weight matrices (PWM) for each TF"). This allowed us to highlight that singleton TF binding events have a great fraction of high quality motifs compared to CRMs.

Reviewer 2:

*The current manuscript is difficult to read and understand. I have several recommendations for revisions, starting with some major re-organization*.

*1) The logical flow is fairly strong in the Results, but the data referred to are dispersed across many pages of Figures and Figure supplements. Also the order of the main figures does not fit with the presentation in the Results: it really is not used until the third section. I strongly recommend re-organizing the figures. Start with some of the current Figure 1 supplements, specifically* [*Figure 1--figure supplement 3*](#fig1s3){ref-type="fig"}*, 4, 5 to show the basic data, and how you constructed the CRMs, and the amount of conservation for TF bound sites and CRMs. Then go to the current* [*Figure 1*](#fig1){ref-type="fig"}*, which describes how the CRMs are categorized by extent of conservation*.

We have taken the reviewer's suggestion and re-organized our figures as recommended. We have also added an additional summary ([Figure 1](#fig1){ref-type="fig"}) to illustrate how we designated CRMs. This also addressed Reviewer 1's concern about the lack of detail and presentation of the CRM analysis. We have also condensed our functional enrichments into one Figure (see comment below) and condensed the section on the HGMD enrichments. Overall we feel these changes have strengthened the paper and we thank the reviewer for this suggestion.

*2)* [*Figure 2*](#fig2){ref-type="fig"} *and the many supplemental figures have multiple problems. The authors have developed an excellent way of displaying the GREAT results, but they flood the reader with too much information. A better-digested and focused set of key results needs to be featured. The text does have a good focus; however, the text and figures are not closely aligned. The specific examples of significant enrichments in the text are not listed in the main* [*Figure 2*](#fig2){ref-type="fig"}*, and the reader has to scan through four or five pages of figure supplements to find the data being discussed. One figure highlighting the key enrichments needs to be refined from all this material. Also, the method for assigning likely target genes is not stated in the main text. This is a very important point for interpreting the data, and it should be stated in the Results as well as in the Methods*.

We have now condensed the enrichment analysis into one Figure ([Figure 3](#fig3){ref-type="fig"}) as suggested. This allowed us to remove the many pages of supplemental Figure 2. We also used this to condense the [Figure 5](#fig5){ref-type="fig"} results. We achieved this by recording the top 5 enrichments for the three select databases we discussed in the main text. We then plot all enrichments for any database ontology that is significant in one or more of the comparisons. This should allow the reader to more easily cross-compare the enrichments obtained for different phylogenetic categories, CRMs versus singletons and TF-specific enrichments obtained. The full list of enrichments, associated genes and statistics remain in [Supplemental file 3](#SD8-data){ref-type="supplementary-material"}.

We also state in the Results: "We used the enrichment tool GREAT ([@bib48]) to perform functional enrichments. GREAT's default setting assigns TF binding events to a basal region around every gene (5 kb upstream, 1 kb downstream). ChIP-seq peaks that fall within the basal regulatory region of each gene, as well as the genomic sequence that spans between the basal region of that gene and the nearest gene's basal region (within a maximum of 1 Mb) are used to generate functional enrichments. The most significant enrichments that were unique to the shared liver CRMs include: liver disease (Binomial FDR q-value = 4.53 x 10^-130^) from the Disease Ontology database and metabolism of lipids and lipoproteins (q = 2.96 x 10^-73^) from MSigDB Pathway ([Figure 3A--B](#fig3){ref-type="fig"}; [Figure 3--source data 1A](#SD3-data){ref-type="supplementary-material"})."

*3) The description and interpretation of the data in* [*Figure 4*](#fig4){ref-type="fig"} *need to be more accurate. The data in panel B are over-interpreted in the legend and in the Results. The expression of presumptive targets is not limited to liver ("uniquely expressed") but the expression levels are higher there. The text says "Unlike CRMs, conserved singletons do not show a strong increase in liver-specific gene expression." In fact, presumptive targets of singletons show a similar pattern to the presumptive targets of CRMs, but the levels of expression are lower*.

We revised the description in the legend for [Figure 4B](#fig4){ref-type="fig"} accordingly: "In contrast, gene expression levels near TFs in shared CRMs were significantly higher than those near shared singleton-associated genes (p=2.4 x 10^-16^) ([Figure 5A](#fig5){ref-type="fig"}). Using a reference transcription dataset that comprises RNA-seq data for liver and 15 additional human tissue types (E-MTAB-513) we confirmed the above observation and found that the gene expression association with liver CRMs, and to a lesser extent Singletons, was tissue-specific ([Figure 5B](#fig5){ref-type="fig"}). In sum, deeply shared CRMs are associated with genes that are highly expressed in a distinctly liver-specific manner."

*Is the decrease in signal for deeply shared singletons significant, or is this related to a small number of targets to examine? Also, the legend should specify the RNA-seq data used in panel A. The top comparison in* [*Figure 4A*](#fig4){ref-type="fig"} *seems to be between the expression levels of presumptive targets for deeply conserved CRMs and lineage-specific singletons, but it has a surprisingly high p-value; this should be clarified*.

We have clarified the data source for [Figure 4](#fig4){ref-type="fig"} panel A (now [Figure 5](#fig5){ref-type="fig"}) and provided more details on the analysis in the Methods section. We have added the number of gene associations for [Figure 5A](#fig5){ref-type="fig"} in the legend and 5B on the heatmap itself. To clarify the source of the high p-value the 5-way shared CRMs versus singletons, we also re-plotted the figure for each TF separately, along with the number of TF-associated genes ([Figure 5--figure supplement 1](#fig5s1){ref-type="fig"}). The p-values are less striking but still significant when broken down into individual factors (p\<10^-3^). The reason for this high p-value is likely due to the fact that some very highly expressed liver genes have multiple CRMs close by. Our plot does not show the outliers, which include highly expressed liver genes like Albumin, fibrinogen (FGA, FGG, FGB), complement genes, and many of the acute phase response genes (e.g. CRP, SAA1, SAA2). This analysis has been added to the Results section.

*4)* [*Figure 6*](#fig6){ref-type="fig"} *main and Figure 6--figure supplement 1: The authors are making a critical point but the connections between the text and the Figures are not stated clearly. In the Results, the authors give p-values for enrichment of about 0.005 to 0.008 and refer to* [*Figure 6*](#fig6){ref-type="fig"}*. However, those p-values are MUCH smaller, and correspond to the analysis in the next sentence, after separation by conservation categories. However, the reader is referred to Supplemental File 4, whereas they really need to look at* [*Figure 6*](#fig6){ref-type="fig"}*! The fact that the enrichments are robust to different ways of dealing with potentially functional SNPs in proximity or LD is a strong point and accurately stated in the Results. However, the titles to the figure legends (*[*Figure 6*](#fig6){ref-type="fig"} *vs. Figure 6--figure supplement 1) are the same, and it takes some careful reading to figure out what is different about the two figures*.

We have now removed the results for the "Any shared" enrichments from the text (they are still in the figure and in the supplemental file), and focused our discussion on the deeply shared CRMs. We have corrected the Figure legends. We have also redone [Table 2](#tbl2){ref-type="table"} (now [Table 1](#tbl1){ref-type="table"}) so it includes more interesting information regarding the gene loci and disease trait categories that were enriched for deeply shared CRMs.

*5) The Discussion should address what is missed by focusing on only combinatorial binding, only conserved binding, and both. Clearly, many fewer bound sites are examined by doing this filtering, but the enrichment for likely function is substantial*. *What are the potential costs of taking this approach?*

We have now included this important point in the Discussion, with the text starting "Just as using DNA constraint as a sole criterion for enhancer finding has its limitations, using filtering approaches that require conserved combinatorial binding will also miss important regulatory events near genes of interest".

*6) I would like to see a paragraph in the Discussion comparing the advantages of filtering vs integration*. *Are there integrative approaches that would emphasize the features shown to be useful here (combinatorial binding and conservation) while not completely excluding other binding sites?*

We have addressed this comment in the Reviewer 1, comment 1 and have created a paragraph in the Discussion, which should address comment 5 above as well.

*7) What is the null model for the tests of enrichment for GWAS SNPs in CRMs, singletons (*[*Figure 6*](#fig6){ref-type="fig"}*)? In previous studies, the null model was restricted to SNPs on the genotyping array that were not associated with a trait but were matched to the trait-associated SNPs in several important ways, e.g. allele frequency, position relative to gene structure, and proximity to the transcription start site*.

We implemented two null models to further test the significance of the enrichments we found. First we shuffled the GWAS SNP summary annotation 1,000 times. Using each random set, we annotated CRMs and singletons with the summaries assigned to overlapping SNPs as described for [Figure 7](#fig7){ref-type="fig"}. We then calculated the enrichment for each summary term in the various phylogenetic categories. Second, we created a random set of SNPs from the full list of GWAS lead SNPs that matched the minor allele frequency and distance to transcription start site that we observed in our analyses in [Figure 7](#fig7){ref-type="fig"}. This was repeated 1,000 times to create a null distribution of p-values. We considered an enrichment significant if less than 5% of the 1,000 p-values obtained from either of the two null models had an enrichment p-value equal or lower to the one obtained using the original GWAS SNPs summary annotation sample before multiple testing correction.

[^1]: These authors contributed equally to this work.

[^2]: Syncona Partners LLP, London, United Kingdom.

[^3]: Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.

[^4]: Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, United States.

[^5]: Lead GWAS SNPs and their associated Disease Traits were obtained directly from the NHGRI catalog ([@bib30]). An LD window (r^2^ ≥ 0.8) around each SNP was obtained and regions with identical Disease Traits were collapsed into a single interval. These Disease-Trait--associated intervals were then intersected with all CRMs and Singleton categories as in [Figure 7](#fig7){ref-type="fig"}. This table shows Disease Traits that were significantly enriched for Deeply shared CRMs. The summarized disease category used in [Figure 7](#fig7){ref-type="fig"}, the number of Deeply shared associated CRMs, the Bonferroni corrected p-values from the hypergeometric test, fold enrichment of Deeply shared CRMs, and the nearest gene to the Deeply shared CRM, if it is protein coding, are shown. [Figure 7---source data 1G](#SD4-data){ref-type="supplementary-material"} contains detailed enrichment information including SNP ID and primary GWAS publication (PMID).

[^6]: HGMD disease variants falling within shared CRMs, shared singletons and human only CRMs. The number of unique regulatory mutations designated as 'disease-mutations' in the HGMD database recorded within each CRM or singleton is shown.

[^7]: RMRP is a non-coding RNA that is found in HGMD associated to several related diseases.
